| George Bernard Del Porto, MD | |
|
1470 Tobias Gadson Blvd, Suite 201, Charleston, SC 29407-4707 | |
| (843) 556-7060 | |
| (843) 556-9960 |
| Full Name | George Bernard Del Porto |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Location | 1470 Tobias Gadson Blvd, Charleston, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689673881 | NPI | - | NPPES |
| 064673 | Medicaid | SC | |
| 20 4068094 | Other | SC | TAX ID |
| 1633327071 | Other | SC | SS NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 6467 (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| George Bernard Del Porto, MD 2687 Lake Park Dr, N Charleston, SC 29406-9100 Ph: (843) 572-0097 | George Bernard Del Porto, MD 1470 Tobias Gadson Blvd, Suite 201, Charleston, SC 29407-4707 Ph: (843) 556-7060 |
News Archive
A discovery by Queensland scientists could be the key to stopping damage caused by uncontrolled inflammation in a range of common diseases including liver disease, Alzheimer's and gout.
Indevus Pharmaceuticals, Inc. has announced that it has entered into a co-promotion and licensing agreement with PLIVA d.d. through its specialty branded subsidiary, Odyssey Pharmaceuticals Inc., for the U.S. commercialization of SANCTURA™ (trospium chloride), under review by the U.S. Food and Drug Administration (FDA) as a treatment for overactive bladder.
Patients with chronic pain who took part in a collaborative care intervention that included patient and clinician education and symptom monitoring and feedback to the primary care physician had improvements in pain-related disability and intensity, compared to usual care, according to a study in the March 25 issue of JAMA, the Journal of the American Medical Association.
Oxygen Biotherapeutics, Inc. ("OBI") a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today announced that the protocol of their phase 3 trial for levosimendan has been published on ClinicalTrials.gov, "Levosimendan in Patients with Left Ventricular Systolic Dysfunction Undergoing Heart Surgery on Cardiopulmonary Bypass."
› Verified 2 days ago
Dr. Alexandra Maria-pilar Geada, MD Urology Medicare: Medicare Enrolled Practice Location: 169 Ashley Ave Rm 202, Charleston, SC 29425 Phone: 843-792-7888 | |
Michaella Maloney Prasad, M.D. Urology Medicare: Medicare Enrolled Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
John B Adams Ii, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Katie Flower, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 169 Ashley Ave, Room 202 Main Hospital, Charleston, SC 29425 Phone: 216-385-5459 | |
Stephen Walter Bielsky, M.D. Urology Medicare: Medicare Enrolled Practice Location: 1470 Tobias Gadson Blvd, Suite 201, Charleston, SC 29407 Phone: 843-556-7060 Fax: 843-556-9960 | |
Dr. Timothy Suek, MD Urology Medicare: Medicare Enrolled Practice Location: 169 Ashley Ave Rm 202, Charleston, SC 29425 Phone: 843-792-4538 | |
Lindsey Cassini Cox, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 |